MENU
TCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TScan Therapeutics (TCRX) Earnings Date & Reports
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer... Show more
A.I. Advisor
published Earnings
TCRX is expected to report earnings to fall 7.87% to -21 cents per share on March 10
Q4'26
Est.
$-0.21
Q2'26
Beat
by $0.03
Q1'26
Missed
by $0.04
Q4'25
Beat
by $0.09
Q3'25
Beat
by $0.06
The last earnings report on August 12 showed earnings per share of -23 cents, beating the estimate of -25 cents. With 160.65K shares outstanding, the current market capitalization sits at 12.74M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
830 Winter Street
Phone
+1 857 399-9500
Employees
142
Web
https://www.tscan.com